Hybrid B- and T-Cell Immunity Associates With Protection Against Breakthrough Infection After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Avon Longitudinal Study of Parents and Children (ALSPAC) Participants

Collectively, these results suggest that hybrid B- and T-cell immunity offers superior protection from BI after coronavirus disease 2019 (COVID-19) vaccination, and this finding has implications for designing next-generation COVID-19 vaccines that are capable of eliciting immunity to a broader repertoire of SARS-CoV-2 proteins.

Authors

Institutions

Publication Details

Journal
The Journal of Infectious Diseases
Published
2025-05-15
DOI
https://doi.org/10.1093/infdis/jiaf246
Citations
2
Primary Topic
Health, Environment, Cognitive Aging
Type
article
Field-Weighted Citation Impact
2.40

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Hybrid B- and T-Cell Immunity Associates With Protection Against Breakthrough Infection After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Avon Longitudinal Study of Parents and Children (ALSPAC) Participants

Linda Wooldridge, Anthony Brown, Susan M. Ring, Natalie Di Bartolo et al.
2 citations
The Journal of Infectious Diseases
Health, Environment, Cognitive Aging
2.40
article

Hybrid B- and T-Cell Immunity Associates With Protection Against Breakthrough Infection After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Avon Longitudinal Study of Parents and Children (ALSPAC) Participants

Linda Wooldridge, Anthony Brown, Susan M. Ring, Natalie Di Bartolo, Ashley M. Toye, Laura Rivino, Paul Klenerman, Kapil Gupta, Amy Thomas, Milla Kibble, Adam Finn, Jennifer Oliver, Lynn Molloy, Ore Francis, Ruth E. Mitchell, Kate Northstone, Alice Halliday, Emily Milodowski, Elizabeth Oliver, Anu Goenka, Nicholas J. Timpson, Holly E. Baum, Benjamin Hitchings, Marianna Santopaolo, Andrew D. Davidson, Begonia Morales‐Aza, Melanie Lewcock, Imre Berger, Firona Roth, Divya Diamond, Katrina Entwistle
article en
2 citations

Abstract

Collectively, these results suggest that hybrid B- and T-cell immunity offers superior protection from BI after coronavirus disease 2019 (COVID-19) vaccination, and this finding has implications for designing next-generation COVID-19 vaccines that are capable of eliciting immunity to a broader repertoire of SARS-CoV-2 proteins.

The Journal of Infectious DiseasesVol. 232(2)
King's College London (GB), University of Cambridge (GB), Bristol Royal Hospital for Children (GB), University of Bristol (GB), University of Oxford (GB), Medawar Building for Pathogen Research (GB), Health & Life (Taiwan) (TW), Medical Research Council (GB)
Wellcome Trust, UK Research and Innovation, Academy of Medical Sciences, University of Bristol, Musculoskeletal Research Center, Washington University in St. Louis, Elizabeth Blackwell Institute for Health Research, University of Bristol, Medical Research Council
Good health and well-being
Openalex Percentile: Top 13%
Health, Environment, Cognitive Aging
2.40
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.